These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21576205)

  • 21. The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus.
    Hahn BH
    J Rheumatol Suppl; 1997 May; 48():89-93. PubMed ID: 9150126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.
    Santana-de Anda K; Gómez-Martín D; Monsivais-Urenda AE; Salgado-Bustamante M; González-Amaro R; Alcocer-Varela J
    Clin Exp Immunol; 2014 Dec; 178(3):428-37. PubMed ID: 25130328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
    Karonitsch T; Feierl E; Steiner CW; Dalwigk K; Korb A; Binder N; Rapp A; Steiner G; Scheinecker C; Smolen J; Aringer M
    Arthritis Rheum; 2009 May; 60(5):1463-71. PubMed ID: 19404947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
    Landolt-Marticorena C; Bonventi G; Lubovich A; Ferguson C; Unnithan T; Su J; Gladman DD; Urowitz M; Fortin PR; Wither J
    Ann Rheum Dis; 2009 Sep; 68(9):1440-6. PubMed ID: 18772188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene structures and promoter characteristics of interferon regulatory factor 1 (IRF-1), IRF-2 and IRF-7 from snakehead Channa argus.
    Jia W; Guo Q
    Mol Immunol; 2008 Apr; 45(8):2419-28. PubMed ID: 18291530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK.
    Wang RP; Zhang M; Li Y; Diao FC; Chen D; Zhai Z; Shu HB
    Mol Immunol; 2008 Apr; 45(7):1926-34. PubMed ID: 18068231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells.
    Zhang R; Xing M; Ji X; Gu L; Yang X; Wang H; Jiang P
    Cytokine; 2010 May; 50(2):195-203. PubMed ID: 20303780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus.
    Akahoshi M; Nakashima H; Sadanaga A; Miyake K; Obara K; Tamari M; Hirota T; Matsuda A; Shirakawa T
    Lupus; 2008 Jun; 17(6):568-74. PubMed ID: 18539711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
    Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
    Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
    Liu J; Berthier CC; Kahlenberg JM
    Arthritis Rheumatol; 2017 Sep; 69(9):1840-1849. PubMed ID: 28564495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.
    Santana-de Anda K; Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
    Autoimmun Rev; 2011 Dec; 11(2):98-103. PubMed ID: 21872684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells.
    Salvi V; Bosisio D; Mitola S; Andreoli L; Tincani A; Sozzani S
    Immunobiology; 2010; 215(9-10):756-61. PubMed ID: 20573419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLE - hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor AE
    Arthritis Res Ther; 2003; 5(5):207-9. PubMed ID: 12932278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts.
    Li Q; Tang L; Roberts PC; Kraniak JM; Fridman AL; Kulaeva OI; Tehrani OS; Tainsky MA
    Mol Cancer Res; 2008 May; 6(5):770-84. PubMed ID: 18505922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
    J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.
    Kamiyama R; Yoshimi R; Takeno M; Iribe Y; Tsukahara T; Kishimoto D; Kunishita Y; Sugiyama Y; Tsuchida N; Nakano H; Minegishi K; Tamura M; Asami Y; Kirino Y; Ishigatsubo Y; Ozato K; Nakajima H
    Mod Rheumatol; 2018 Nov; 28(6):993-1003. PubMed ID: 29385873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.